

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.83995969 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.50724182 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.50724182 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 7.48123434 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.20080559 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20080559 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.96026518 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.41571694 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.41571694 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.41571694 |
| 11 | oxidative demethylation (GO:0070989) | 6.40999088 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.06584156 |
| 13 | tryptophan metabolic process (GO:0006568) | 6.06092025 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.99850564 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.88438755 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.76302614 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.70783917 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 5.54526774 |
| 19 | cysteine metabolic process (GO:0006534) | 5.52729538 |
| 20 | urea metabolic process (GO:0019627) | 5.38919540 |
| 21 | urea cycle (GO:0000050) | 5.38919540 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.26137895 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.24283021 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.20792455 |
| 25 | lysine catabolic process (GO:0006554) | 5.14902136 |
| 26 | lysine metabolic process (GO:0006553) | 5.14902136 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.12375939 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.11427466 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 5.09136175 |
| 30 | homocysteine metabolic process (GO:0050667) | 5.04187325 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.98481306 |
| 32 | bile acid metabolic process (GO:0008206) | 4.97273579 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.94403245 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.89326183 |
| 35 | protein carboxylation (GO:0018214) | 4.88711374 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88711374 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.77958174 |
| 38 | negative regulation of protein activation cascade (GO:2000258) | 4.77625786 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.76844381 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.73568856 |
| 41 | S-adenosylmethionine metabolic process (GO:0046500) | 4.72472321 |
| 42 | alkaloid metabolic process (GO:0009820) | 4.72184650 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.68321843 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.65484928 |
| 45 | drug catabolic process (GO:0042737) | 4.61199479 |
| 46 | complement activation, alternative pathway (GO:0006957) | 4.59166385 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 4.58637672 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.55644958 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.55265359 |
| 50 | cellular biogenic amine catabolic process (GO:0042402) | 4.52111277 |
| 51 | amine catabolic process (GO:0009310) | 4.52111277 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.51540741 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.51540741 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.50898140 |
| 55 | ethanol metabolic process (GO:0006067) | 4.46322275 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.45614551 |
| 57 | macromolecular complex remodeling (GO:0034367) | 4.45614551 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45614551 |
| 59 | cellular glucuronidation (GO:0052695) | 4.41332590 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.40168453 |
| 61 | acylglycerol homeostasis (GO:0055090) | 4.40168453 |
| 62 | negative regulation of complement activation (GO:0045916) | 4.39183047 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.38777621 |
| 64 | phospholipid efflux (GO:0033700) | 4.37920194 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.32588875 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.32242782 |
| 67 | protein activation cascade (GO:0072376) | 4.31281624 |
| 68 | glutamate metabolic process (GO:0006536) | 4.28673922 |
| 69 | glycine metabolic process (GO:0006544) | 4.27634171 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 4.25686395 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.23654088 |
| 72 | drug transmembrane transport (GO:0006855) | 4.23481288 |
| 73 | regulation of complement activation (GO:0030449) | 4.21613148 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 4.13868542 |
| 75 | urate metabolic process (GO:0046415) | 4.13593014 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 4.12426070 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 4.11253223 |
| 78 | ethanol oxidation (GO:0006069) | 4.08051305 |
| 79 | aldehyde catabolic process (GO:0046185) | 4.06260374 |
| 80 | serine family amino acid biosynthetic process (GO:0009070) | 4.05175012 |
| 81 | ketone body metabolic process (GO:1902224) | 4.04863132 |
| 82 | complement activation (GO:0006956) | 4.02023843 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 4.01313591 |
| 84 | uronic acid metabolic process (GO:0006063) | 4.00693332 |
| 85 | glucuronate metabolic process (GO:0019585) | 4.00693332 |
| 86 | exogenous drug catabolic process (GO:0042738) | 3.96519535 |
| 87 | cholesterol efflux (GO:0033344) | 3.95387269 |
| 88 | xenobiotic catabolic process (GO:0042178) | 3.94995748 |
| 89 | regulation of humoral immune response (GO:0002920) | 3.93978331 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93302685 |
| 91 | organic acid catabolic process (GO:0016054) | 3.90404827 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.90404827 |
| 93 | complement activation, classical pathway (GO:0006958) | 3.89032749 |
| 94 | arginine metabolic process (GO:0006525) | 3.88411339 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.86040749 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85586903 |
| 97 | opsonization (GO:0008228) | 3.76847223 |
| 98 | negative regulation of hemostasis (GO:1900047) | 3.74355031 |
| 99 | negative regulation of blood coagulation (GO:0030195) | 3.74355031 |
| 100 | regulation of plasminogen activation (GO:0010755) | 3.73503921 |
| 101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73375447 |
| 102 | NAD biosynthetic process (GO:0009435) | 3.73371012 |
| 103 | plasma lipoprotein particle assembly (GO:0034377) | 3.72462127 |
| 104 | flavonoid metabolic process (GO:0009812) | 3.71059491 |
| 105 | aspartate family amino acid catabolic process (GO:0009068) | 3.70123911 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.69201606 |
| 107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.69201606 |
| 108 | carnitine metabolic process (GO:0009437) | 3.68118572 |
| 109 | drug metabolic process (GO:0017144) | 3.68007364 |
| 110 | L-methionine salvage (GO:0071267) | 3.67791235 |
| 111 | L-methionine biosynthetic process (GO:0071265) | 3.67791235 |
| 112 | amino acid salvage (GO:0043102) | 3.67791235 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.67071083 |
| 114 | acute-phase response (GO:0006953) | 3.66918102 |
| 115 | fatty acid oxidation (GO:0019395) | 3.63928642 |
| 116 | fatty acid beta-oxidation (GO:0006635) | 3.63199403 |
| 117 | monocarboxylic acid catabolic process (GO:0072329) | 3.63133643 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62617921 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62617921 |
| 120 | cytolysis (GO:0019835) | 3.62171687 |
| 121 | cofactor catabolic process (GO:0051187) | 3.61461603 |
| 122 | arginine catabolic process (GO:0006527) | 3.61184665 |
| 123 | fibrinolysis (GO:0042730) | 3.61033472 |
| 124 | negative regulation of lipase activity (GO:0060192) | 3.60570588 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 3.59634106 |
| 126 | heme transport (GO:0015886) | 3.56138016 |
| 127 | xenobiotic metabolic process (GO:0006805) | 3.55393739 |
| 128 | negative regulation of wound healing (GO:0061045) | 3.41514940 |
| 129 | negative regulation of coagulation (GO:0050819) | 3.38176501 |
| 130 | negative regulation of humoral immune response (GO:0002921) | 3.36785443 |
| 131 | steroid catabolic process (GO:0006706) | 3.33086281 |
| 132 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.19948529 |
| 133 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.19948529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33298941 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.07922481 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02735316 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45022408 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.18763485 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.07448536 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.62693988 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.07932654 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89655222 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10954028 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.49012631 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.45106989 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.40280785 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.34015692 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.20315114 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16040977 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14583722 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08977357 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5622213 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.94606913 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93227916 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85778681 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83261218 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73474139 |
| 25 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.68388372 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65938647 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59745753 |
| 28 | STAT3_23295773_ChIP-Seq_U87_Human | 1.59266073 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.56072008 |
| 30 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.56072008 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55255221 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51530421 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47876270 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46051593 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46002440 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43106260 |
| 37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43061626 |
| 38 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.42357944 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41949168 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41754799 |
| 41 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.36872135 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36431662 |
| 43 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33334314 |
| 44 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33334314 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31930984 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29780579 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29444055 |
| 48 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.29428341 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26354401 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26082684 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25126146 |
| 52 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24510603 |
| 53 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22955367 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22755395 |
| 55 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21491588 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21441307 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18780673 |
| 58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16606703 |
| 59 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16549395 |
| 60 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15916905 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15721604 |
| 62 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15654991 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12614567 |
| 64 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12543512 |
| 65 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12080732 |
| 66 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12080732 |
| 67 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11836619 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11540883 |
| 69 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11244475 |
| 70 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10499542 |
| 71 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.09100697 |
| 72 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08615702 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06766740 |
| 74 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.06259341 |
| 75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06162559 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05403122 |
| 77 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05099353 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05064630 |
| 79 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04268439 |
| 80 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04156196 |
| 81 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02465068 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02253490 |
| 83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02253490 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01588267 |
| 85 | NFYA_21822215_ChIP-Seq_K562_Human | 1.01471374 |
| 86 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01106612 |
| 87 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.00355367 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00133019 |
| 89 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99438664 |
| 90 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99329048 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96179560 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94800036 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94722562 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92260439 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89358732 |
| 96 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85205398 |
| 97 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85205394 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83013054 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75689835 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74885436 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74806071 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71993743 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71233195 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.70527550 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70313408 |
| 106 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69437566 |
| 107 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69359804 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69357883 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69357883 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68959817 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66921367 |
| 112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.66472748 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66065302 |
| 114 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.65393057 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64901310 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64066320 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63964747 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63308214 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62785686 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62621649 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61611112 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61000165 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.60534597 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.59280746 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58144722 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57848096 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.57702812 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57412868 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56618094 |
| 130 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.56451739 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54286483 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53772462 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53604455 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.52608890 |
| 135 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52005581 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51478889 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.50792869 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50446475 |
| 139 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.50171753 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49338390 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.48458119 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48306043 |
| 143 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.48253328 |
| 144 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.46694607 |
| 145 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.45917655 |
| 146 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.45297083 |
| 147 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44599044 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44584298 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44202801 |
| 150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43858109 |
| 151 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43357391 |
| 152 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.42448764 |
| 153 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42204927 |
| 154 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.41442153 |
| 155 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.41354689 |
| 156 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.40697754 |
| 157 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40579444 |
| 158 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.40577452 |
| 159 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39086582 |
| 160 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38338100 |
| 161 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.38013142 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37419631 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36739908 |
| 164 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36595095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.39081680 |
| 2 | MP0005360_urolithiasis | 7.69079154 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.22642790 |
| 4 | MP0005365_abnormal_bile_salt | 6.03805863 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.28569277 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.99694429 |
| 7 | MP0003252_abnormal_bile_duct | 3.95364666 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.35982133 |
| 9 | MP0003195_calcinosis | 3.13059631 |
| 10 | MP0005332_abnormal_amino_acid | 3.11321227 |
| 11 | MP0009840_abnormal_foam_cell | 2.91893452 |
| 12 | MP0005083_abnormal_biliary_tract | 2.80292448 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.69079891 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.50107094 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.40359240 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.11009911 |
| 17 | MP0000609_abnormal_liver_physiology | 2.04121404 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.02963572 |
| 19 | MP0005451_abnormal_body_composition | 1.87586056 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81835053 |
| 21 | MP0001764_abnormal_homeostasis | 1.77868657 |
| 22 | MP0003868_abnormal_feces_composition | 1.77189766 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59176051 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.57758133 |
| 25 | MP0009697_abnormal_copulation | 1.54877721 |
| 26 | MP0003186_abnormal_redox_activity | 1.45698121 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.39386220 |
| 28 | MP0003011_delayed_dark_adaptation | 1.26600345 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.20343486 |
| 30 | MP0009764_decreased_sensitivity_to | 1.19215877 |
| 31 | MP0005187_abnormal_penis_morphology | 1.18648518 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.12001717 |
| 33 | MP0005647_abnormal_sex_gland | 1.10849228 |
| 34 | MP0000598_abnormal_liver_morphology | 1.10044162 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.06030898 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.05399722 |
| 37 | MP0003646_muscle_fatigue | 1.02617944 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.02159043 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.00288692 |
| 40 | MP0010386_abnormal_urinary_bladder | 0.99601971 |
| 41 | MP0001968_abnormal_touch/_nociception | 0.98842296 |
| 42 | MP0009763_increased_sensitivity_to | 0.95764065 |
| 43 | MP0005408_hypopigmentation | 0.95331354 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.94574288 |
| 45 | MP0001756_abnormal_urination | 0.93271388 |
| 46 | MP0005670_abnormal_white_adipose | 0.92620386 |
| 47 | MP0008469_abnormal_protein_level | 0.90619009 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.90232673 |
| 49 | MP0009642_abnormal_blood_homeostasis | 0.89262380 |
| 50 | MP0002254_reproductive_system_inflammat | 0.88857552 |
| 51 | MP0000569_abnormal_digit_pigmentation | 0.86948828 |
| 52 | MP0000604_amyloidosis | 0.85856549 |
| 53 | MP0004043_abnormal_pH_regulation | 0.85036016 |
| 54 | MP0002102_abnormal_ear_morphology | 0.83123178 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 0.81860770 |
| 56 | MP0009745_abnormal_behavioral_response | 0.79868654 |
| 57 | MP0002136_abnormal_kidney_physiology | 0.78914821 |
| 58 | MP0002736_abnormal_nociception_after | 0.78796803 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 0.76315478 |
| 60 | MP0004142_abnormal_muscle_tone | 0.75568062 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.75555429 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.75240620 |
| 63 | MP0002282_abnormal_trachea_morphology | 0.72947318 |
| 64 | MP0005535_abnormal_body_temperature | 0.71358660 |
| 65 | MP0003879_abnormal_hair_cell | 0.70545219 |
| 66 | MP0001984_abnormal_olfaction | 0.69769347 |
| 67 | MP0002090_abnormal_vision | 0.69132230 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 0.69064336 |
| 69 | MP0005334_abnormal_fat_pad | 0.67218739 |
| 70 | MP0000427_abnormal_hair_cycle | 0.66608127 |
| 71 | MP0006276_abnormal_autonomic_nervous | 0.65531144 |
| 72 | MP0005253_abnormal_eye_physiology | 0.65418219 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.64542717 |
| 74 | MP0002971_abnormal_brown_adipose | 0.64317156 |
| 75 | MP0009046_muscle_twitch | 0.63794203 |
| 76 | MP0008877_abnormal_DNA_methylation | 0.63719357 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.63108565 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 0.62683669 |
| 79 | MP0001661_extended_life_span | 0.62567629 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.62475031 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.62196172 |
| 82 | MP0006292_abnormal_olfactory_placode | 0.61385846 |
| 83 | MP0002638_abnormal_pupillary_reflex | 0.60601477 |
| 84 | MP0002928_abnormal_bile_duct | 0.59076724 |
| 85 | MP0005395_other_phenotype | 0.58295656 |
| 86 | MP0003724_increased_susceptibility_to | 0.58295542 |
| 87 | MP0005410_abnormal_fertilization | 0.57748949 |
| 88 | MP0005266_abnormal_metabolism | 0.57712837 |
| 89 | MP0003718_maternal_effect | 0.55425825 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.55144672 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.54443703 |
| 92 | MP0002272_abnormal_nervous_system | 0.53336660 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.51845784 |
| 94 | MP0004924_abnormal_behavior | 0.51845784 |
| 95 | MP0003690_abnormal_glial_cell | 0.51744173 |
| 96 | MP0001486_abnormal_startle_reflex | 0.50714311 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.50380539 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.50344564 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.50178349 |
| 100 | MP0009053_abnormal_anal_canal | 0.49723295 |
| 101 | MP0005448_abnormal_energy_balance | 0.49283861 |
| 102 | MP0004130_abnormal_muscle_cell | 0.46954903 |
| 103 | MP0003045_fibrosis | 0.46477909 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.46039962 |
| 105 | MP0000639_abnormal_adrenal_gland | 0.45629932 |
| 106 | MP0002168_other_aberrant_phenotype | 0.45568843 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.45163224 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.44867750 |
| 109 | MP0003633_abnormal_nervous_system | 0.44560463 |
| 110 | MP0003953_abnormal_hormone_level | 0.44079620 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.44050410 |
| 112 | MP0004381_abnormal_hair_follicle | 0.43940745 |
| 113 | MP0003436_decreased_susceptibility_to | 0.43879334 |
| 114 | MP0003880_abnormal_central_pattern | 0.42605637 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.42489399 |
| 116 | MP0002938_white_spotting | 0.42086657 |
| 117 | MP0008874_decreased_physiological_sensi | 0.42042598 |
| 118 | MP0008872_abnormal_physiological_respon | 0.41908599 |
| 119 | MP0003329_amyloid_beta_deposits | 0.41582994 |
| 120 | MP0000538_abnormal_urinary_bladder | 0.39825659 |
| 121 | MP0008873_increased_physiological_sensi | 0.38079155 |
| 122 | MP0002822_catalepsy | 0.35986012 |
| 123 | MP0006082_CNS_inflammation | 0.35354838 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.34612603 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.34210680 |
| 126 | MP0001853_heart_inflammation | 0.34055601 |
| 127 | MP0009115_abnormal_fat_cell | 0.32106314 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.30891309 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.30602997 |
| 130 | MP0002132_abnormal_respiratory_system | 0.29892774 |
| 131 | MP0005166_decreased_susceptibility_to | 0.29180451 |
| 132 | MP0002796_impaired_skin_barrier | 0.28601451 |
| 133 | MP0003075_altered_response_to | 0.28106744 |
| 134 | MP0005058_abnormal_lysosome_morphology | 0.28040474 |
| 135 | MP0009672_abnormal_birth_weight | 0.27199441 |
| 136 | MP0002837_dystrophic_cardiac_calcinosis | 0.24275811 |
| 137 | MP0000249_abnormal_blood_vessel | 0.23441840 |
| 138 | MP0002970_abnormal_white_adipose | 0.23408773 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.22743949 |
| 140 | MP0001243_abnormal_dermal_layer | 0.21453218 |
| 141 | MP0000579_abnormal_nail_morphology | 0.21427174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19235689 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.79273801 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.54997395 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.31582462 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.03661305 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.97971309 |
| 7 | Xanthomatosis (HP:0000991) | 5.88244730 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.09996780 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.67029699 |
| 10 | Hyperammonemia (HP:0001987) | 4.62781569 |
| 11 | Hyperglycinemia (HP:0002154) | 4.56323150 |
| 12 | Hyperglycinuria (HP:0003108) | 4.55578726 |
| 13 | Joint hemorrhage (HP:0005261) | 4.53715097 |
| 14 | Ketosis (HP:0001946) | 4.44434527 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.40360362 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.39334312 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.32294241 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.32294241 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26823994 |
| 20 | Complement deficiency (HP:0004431) | 4.26482866 |
| 21 | Epidermoid cyst (HP:0200040) | 4.22253211 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.11805750 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.02470052 |
| 24 | Fat malabsorption (HP:0002630) | 3.90407715 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.87361270 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.85129264 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.84230189 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.77079292 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76224520 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.74128330 |
| 31 | Fair hair (HP:0002286) | 3.64579278 |
| 32 | Abnormality of nucleobase metabolism (HP:0010932) | 3.45020010 |
| 33 | Ketoacidosis (HP:0001993) | 3.40075401 |
| 34 | Delayed CNS myelination (HP:0002188) | 3.38450633 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37493387 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.36862887 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33966466 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.29133423 |
| 39 | Gout (HP:0001997) | 3.28896533 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.25414921 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.19743082 |
| 42 | Abnormal biliary tract physiology (HP:0012439) | 3.09844890 |
| 43 | Bile duct proliferation (HP:0001408) | 3.09844890 |
| 44 | Hyperventilation (HP:0002883) | 3.09094191 |
| 45 | Metabolic acidosis (HP:0001942) | 3.06619430 |
| 46 | Abnormality of complement system (HP:0005339) | 3.06179703 |
| 47 | Vascular calcification (HP:0004934) | 2.98509568 |
| 48 | Steatorrhea (HP:0002570) | 2.93653212 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.90474119 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.90474119 |
| 51 | Lethargy (HP:0001254) | 2.84380577 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.83475525 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.82166645 |
| 54 | Proximal tubulopathy (HP:0000114) | 2.81523174 |
| 55 | Nephritis (HP:0000123) | 2.74420822 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.73510846 |
| 57 | Generalized hypopigmentation of hair (HP:0011358) | 2.68979402 |
| 58 | Alkalosis (HP:0001948) | 2.63879947 |
| 59 | Myocardial infarction (HP:0001658) | 2.62145075 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.61975582 |
| 61 | Spontaneous abortion (HP:0005268) | 2.51927418 |
| 62 | Pancreatic cysts (HP:0001737) | 2.51813034 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.49671366 |
| 64 | Cerebral edema (HP:0002181) | 2.49450717 |
| 65 | Malnutrition (HP:0004395) | 2.47001793 |
| 66 | Skin nodule (HP:0200036) | 2.46870564 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.46407746 |
| 68 | Irritability (HP:0000737) | 2.46254532 |
| 69 | Increased purine levels (HP:0004368) | 2.43940363 |
| 70 | Hyperuricemia (HP:0002149) | 2.43940363 |
| 71 | Enlarged kidneys (HP:0000105) | 2.42913049 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.37384978 |
| 73 | Glycosuria (HP:0003076) | 2.37384978 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.37083363 |
| 75 | Chronic hepatic failure (HP:0100626) | 2.36429794 |
| 76 | Abnormality of the renal cortex (HP:0011035) | 2.34451315 |
| 77 | Vomiting (HP:0002013) | 2.34424304 |
| 78 | Rickets (HP:0002748) | 2.32817306 |
| 79 | Spastic diplegia (HP:0001264) | 2.32691221 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.30917032 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.30917032 |
| 82 | Mitral stenosis (HP:0001718) | 2.30163591 |
| 83 | Acanthocytosis (HP:0001927) | 2.29216607 |
| 84 | Renal cortical cysts (HP:0000803) | 2.27417784 |
| 85 | Neonatal onset (HP:0003623) | 2.24627244 |
| 86 | Pancreatitis (HP:0001733) | 2.20918858 |
| 87 | Glomerulonephritis (HP:0000099) | 2.20737985 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.18285872 |
| 89 | Arthropathy (HP:0003040) | 2.17831753 |
| 90 | Hypothermia (HP:0002045) | 2.15295038 |
| 91 | Late onset (HP:0003584) | 2.14604093 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.13517292 |
| 93 | Congenital stationary night blindness (HP:0007642) | 2.12554956 |
| 94 | Cholecystitis (HP:0001082) | 2.11217857 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.11217857 |
| 96 | Brushfield spots (HP:0001088) | 2.11216905 |
| 97 | Opisthotonus (HP:0002179) | 2.11074512 |
| 98 | Cholelithiasis (HP:0001081) | 2.09253508 |
| 99 | Pancreatic fibrosis (HP:0100732) | 2.06863210 |
| 100 | Pulmonary embolism (HP:0002204) | 2.05627442 |
| 101 | Esophageal varix (HP:0002040) | 2.04531233 |
| 102 | Hypophosphatemic rickets (HP:0004912) | 2.03378561 |
| 103 | True hermaphroditism (HP:0010459) | 2.02490060 |
| 104 | Menorrhagia (HP:0000132) | 2.01414464 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99709023 |
| 106 | Attenuation of retinal blood vessels (HP:0007843) | 1.96698502 |
| 107 | Gaze-evoked nystagmus (HP:0000640) | 1.96482812 |
| 108 | Abnormality of alanine metabolism (HP:0010916) | 1.95839874 |
| 109 | Hyperalaninemia (HP:0003348) | 1.95839874 |
| 110 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.95839874 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93353077 |
| 112 | Blue irides (HP:0000635) | 1.92577531 |
| 113 | Osteomalacia (HP:0002749) | 1.90549160 |
| 114 | Gingival bleeding (HP:0000225) | 1.89500768 |
| 115 | Thrombophlebitis (HP:0004418) | 1.89131171 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88074582 |
| 117 | Amyloidosis (HP:0011034) | 1.87720950 |
| 118 | Elevated hepatic transaminases (HP:0002910) | 1.87370842 |
| 119 | Nausea (HP:0002018) | 1.86939024 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.85082502 |
| 121 | Abnormality of the gallbladder (HP:0005264) | 1.82913576 |
| 122 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82776381 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 1.80290049 |
| 124 | Poikilocytosis (HP:0004447) | 1.79078411 |
| 125 | Abnormality of midbrain morphology (HP:0002418) | 1.76801112 |
| 126 | Molar tooth sign on MRI (HP:0002419) | 1.76801112 |
| 127 | Neonatal hypoglycemia (HP:0001998) | 1.74942207 |
| 128 | Hyperphosphaturia (HP:0003109) | 1.72160581 |
| 129 | Nephronophthisis (HP:0000090) | 1.69530510 |
| 130 | Decreased central vision (HP:0007663) | 1.67766781 |
| 131 | Cerebral palsy (HP:0100021) | 1.66500784 |
| 132 | Tubulointerstitial nephritis (HP:0001970) | 1.65825446 |
| 133 | Facial shape deformation (HP:0011334) | 1.65524285 |
| 134 | Potter facies (HP:0002009) | 1.65524285 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.64455775 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.63829314 |
| 137 | Congenital hepatic fibrosis (HP:0002612) | 1.62530850 |
| 138 | Inability to walk (HP:0002540) | 1.60306235 |
| 139 | Cystic liver disease (HP:0006706) | 1.57803145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.27713529 |
| 2 | FGFR4 | 4.00925059 |
| 3 | SIK1 | 3.90361845 |
| 4 | INSRR | 3.44705380 |
| 5 | ERN1 | 3.26131739 |
| 6 | MAP4K2 | 2.90512338 |
| 7 | ADRBK2 | 2.89636503 |
| 8 | TAOK3 | 2.64737966 |
| 9 | BMPR1B | 2.58999974 |
| 10 | ERBB4 | 2.46418421 |
| 11 | MST1R | 2.27449645 |
| 12 | WNK3 | 2.27183670 |
| 13 | PIK3CG | 2.11301125 |
| 14 | STK38L | 2.07393486 |
| 15 | ACVR1B | 2.06034477 |
| 16 | FLT3 | 1.98346683 |
| 17 | ZAK | 1.94971442 |
| 18 | MAP2K4 | 1.94721327 |
| 19 | IRAK3 | 1.93800089 |
| 20 | CASK | 1.85649610 |
| 21 | MAP3K14 | 1.85257139 |
| 22 | MAPK11 | 1.71788868 |
| 23 | OXSR1 | 1.71327142 |
| 24 | MAPK13 | 1.70030419 |
| 25 | WNK4 | 1.65280781 |
| 26 | MAP3K4 | 1.60218332 |
| 27 | ABL2 | 1.52030301 |
| 28 | NTRK3 | 1.50823393 |
| 29 | TYK2 | 1.49016346 |
| 30 | PINK1 | 1.45995002 |
| 31 | PKN2 | 1.45665185 |
| 32 | FRK | 1.42660702 |
| 33 | NEK9 | 1.39210376 |
| 34 | LATS1 | 1.38999039 |
| 35 | KDR | 1.35786785 |
| 36 | TNK2 | 1.33131656 |
| 37 | PRKAA2 | 1.22335146 |
| 38 | STK39 | 1.19988008 |
| 39 | PAK3 | 1.18332679 |
| 40 | TIE1 | 1.16859926 |
| 41 | SGK2 | 1.15391174 |
| 42 | PRKCE | 1.10992428 |
| 43 | DAPK2 | 1.09363679 |
| 44 | ADRBK1 | 1.06691754 |
| 45 | EIF2AK3 | 1.06575594 |
| 46 | TXK | 1.05156642 |
| 47 | SGK3 | 1.02720600 |
| 48 | MAP3K7 | 1.00819680 |
| 49 | TBK1 | 1.00604193 |
| 50 | FER | 1.00050742 |
| 51 | TRIM28 | 0.99375374 |
| 52 | JAK2 | 0.99004453 |
| 53 | SGK494 | 0.98776684 |
| 54 | SGK223 | 0.98776684 |
| 55 | TNIK | 0.98522889 |
| 56 | MAPK4 | 0.97912170 |
| 57 | PTK6 | 0.97865495 |
| 58 | MKNK2 | 0.95958411 |
| 59 | MAP3K3 | 0.92038666 |
| 60 | IRAK1 | 0.91698112 |
| 61 | PRKCZ | 0.90655547 |
| 62 | BCR | 0.89706956 |
| 63 | IRAK2 | 0.89439040 |
| 64 | JAK1 | 0.89202868 |
| 65 | MAPK15 | 0.89020459 |
| 66 | GRK6 | 0.88601207 |
| 67 | NLK | 0.87259378 |
| 68 | PTK2B | 0.86485629 |
| 69 | EPHA3 | 0.84130881 |
| 70 | MAP2K3 | 0.83503002 |
| 71 | TEC | 0.83373458 |
| 72 | MUSK | 0.82620692 |
| 73 | FGFR2 | 0.80532668 |
| 74 | MAP2K6 | 0.77347006 |
| 75 | GRK1 | 0.76421874 |
| 76 | CSNK1A1L | 0.76136382 |
| 77 | IKBKE | 0.75460474 |
| 78 | PBK | 0.73202003 |
| 79 | AKT3 | 0.71659739 |
| 80 | PRKAA1 | 0.71366540 |
| 81 | ERBB2 | 0.70989090 |
| 82 | PRKACG | 0.70443029 |
| 83 | CSNK1G2 | 0.70396154 |
| 84 | GSK3A | 0.70196944 |
| 85 | TGFBR2 | 0.70056631 |
| 86 | TLK1 | 0.69655816 |
| 87 | CSNK1G3 | 0.68669006 |
| 88 | PRKACA | 0.67022859 |
| 89 | CAMKK2 | 0.66230940 |
| 90 | PDK3 | 0.66159404 |
| 91 | PDK4 | 0.66159404 |
| 92 | DYRK1B | 0.66046607 |
| 93 | ERBB3 | 0.65630027 |
| 94 | MAPK12 | 0.65476790 |
| 95 | CSK | 0.64668491 |
| 96 | MARK1 | 0.64450399 |
| 97 | MAPKAPK3 | 0.63857051 |
| 98 | CSNK1D | 0.63133255 |
| 99 | PLK2 | 0.62147496 |
| 100 | MAPK7 | 0.62097239 |
| 101 | PRKG1 | 0.61753147 |
| 102 | MAP3K11 | 0.61540200 |
| 103 | CAMK2G | 0.59000610 |
| 104 | STK16 | 0.56343712 |
| 105 | OBSCN | 0.55742960 |
| 106 | IRAK4 | 0.55633015 |
| 107 | MET | 0.54465139 |
| 108 | CSNK1A1 | 0.53296422 |
| 109 | CDK6 | 0.52555846 |
| 110 | CAMK2A | 0.51526057 |
| 111 | STK3 | 0.50572121 |
| 112 | TGFBR1 | 0.49422759 |
| 113 | PRKCQ | 0.49321977 |
| 114 | PDK2 | 0.48557993 |
| 115 | CAMK1D | 0.46868621 |
| 116 | BRSK2 | 0.46708949 |
| 117 | PRKCB | 0.46210166 |
| 118 | GRK7 | 0.45942088 |
| 119 | TRPM7 | 0.45295387 |
| 120 | PRKACB | 0.44956788 |
| 121 | MAP3K13 | 0.44297155 |
| 122 | CSNK1G1 | 0.43438460 |
| 123 | BLK | 0.43271536 |
| 124 | MAP2K7 | 0.42181809 |
| 125 | MAP3K10 | 0.41765596 |
| 126 | FGFR3 | 0.41449659 |
| 127 | DYRK2 | 0.41094091 |
| 128 | IGF1R | 0.40682553 |
| 129 | CSF1R | 0.39722338 |
| 130 | TAOK2 | 0.38868263 |
| 131 | EPHB1 | 0.37572788 |
| 132 | PRKCG | 0.36939779 |
| 133 | PTK2 | 0.36769149 |
| 134 | PDPK1 | 0.36396674 |
| 135 | GRK5 | 0.36282555 |
| 136 | MST4 | 0.36274077 |
| 137 | ITK | 0.34103326 |
| 138 | CHUK | 0.34046906 |
| 139 | DYRK1A | 0.33999726 |
| 140 | PKN1 | 0.33369560 |
| 141 | PRKCA | 0.32536401 |
| 142 | PLK4 | 0.32123693 |
| 143 | CAMK4 | 0.31332427 |
| 144 | PHKG2 | 0.30784454 |
| 145 | PHKG1 | 0.30784454 |
| 146 | MAP3K5 | 0.30002814 |
| 147 | EPHA4 | 0.29896306 |
| 148 | KIT | 0.29734409 |
| 149 | IKBKB | 0.26729317 |
| 150 | MYLK | 0.25887435 |
| 151 | PIK3CA | 0.25798509 |
| 152 | STK38 | 0.24952537 |
| 153 | CDK4 | 0.24741778 |
| 154 | EIF2AK2 | 0.24300333 |
| 155 | ABL1 | 0.23775462 |
| 156 | NUAK1 | 0.22788993 |
| 157 | MAP3K6 | 0.22248965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14302854 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.56758749 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.11634556 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09807691 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.87592460 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80475467 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75967615 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66034348 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56768095 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55475236 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51665147 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45562987 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35753829 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.33852716 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.24033940 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18637950 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15344422 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97155490 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97043256 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96816203 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92064819 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89997122 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88559866 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87936894 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85905614 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.82691054 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77448086 |
| 28 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.63669869 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60702480 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59918431 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57312759 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54082428 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52593078 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52560028 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52080667 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49195921 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45992704 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43267971 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39495781 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36285475 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34047885 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28355192 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24620910 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23399569 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21905408 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18787194 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17961192 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15733190 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11775080 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09682786 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05161446 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03783986 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02011910 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01756939 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01152755 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96267741 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.88762509 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85228733 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79814255 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77396672 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74736962 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73793848 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73072941 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60784270 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58452809 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56671191 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.51456564 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47656068 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.46497850 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34597396 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33766914 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32838730 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31742969 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30518422 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29420134 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26024836 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25877373 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21459452 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20117235 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.17673875 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14463372 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.14253807 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11879144 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10148232 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.09659232 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.08857707 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.08644669 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06905360 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.06357710 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.06101641 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.03989100 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02368107 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.01938114 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.01474091 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00889772 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2477982 |
| 97 | Lysosome_Homo sapiens_hsa04142 | -0.2416962 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.2265905 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2070302 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2053517 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1999487 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1876071 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1857235 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1856183 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1762657 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1761972 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1748664 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | -0.1667057 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.1365013 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1049352 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0878773 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0780158 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0549969 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0492708 |
| 115 | Morphine addiction_Homo sapiens_hsa05032 | -0.0433953 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0361515 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.0330298 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | -0.0257127 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0185084 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0167031 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0143272 |
| 122 | Insulin secretion_Homo sapiens_hsa04911 | -0.0114144 |

